A Modified Calculation Formula for Meibomian Gland Grading

Status Completed

Clinical Trial Summary

The meibomian gland (MG) is a modified sebaceous gland located in the upper and lower eyelids. The grades of MG loss (i.e. meiboscore) is calculated as the ratio between the area of the MGs and the eyelids, and this calculation is based on the two-dimensional digital infrared images.In the current formula, the area of the eyelid is the denominator. However, because the eyelids need to be flipped over for the examination and evaluation, and there may be interobserver variability in the measurement of the area of the eyelids. Aging and involutional eyelid disorders, such as ptosis, ectropion, and entropion, may lead to laxity or deformation of eyelids, and impact the shape and area of eyelid area consequently.These factors could cause inaccuracy in current evaluation method, and impact the grading and evaluation of treatment efficacy of MGD, especially in self-controlled studies, such as in clinical trials. In this study, the investigators propose to use a modified calculation formula for the grading of MGs. The investigators could measure the white to white (WTW) distance of cornea, and then calculate the area of cornea (i.e. corneal base area) accordingly.Unlike the eyelid, the WTW distance does not change significantly during aging or between sexes.Thus, the investigators hypothesize that using the corneal base area as the new denominator in the formula for the grading of MG loss is a better way comparing with the conventional method.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Meibomian Gland Dysfunction

Clinical Trial Details

NCT number	NCT06106737
Study type	Observational
Source	Zhongnan Hospital
Contact
Status	Completed
Phase
Start date	April 1, 2023
Completion date	May 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05062564` - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye	N/A
Completed	`NCT04884243` - Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction	Phase 2
Active, not recruiting	`NCT04425551` - Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction	N/A
Terminated	`NCT02596919` - Fast Infrared Meibography (Photography)	N/A
Completed	`NCT01207752` - The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction	N/A
Completed	`NCT05162261` - to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction	N/A
Recruiting	`NCT06064071` - Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD	N/A
Completed	`NCT03652051` - A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Disease (DED)	Phase 2
Recruiting	`NCT03767530` - Efficacy and Safety of Thermic Devices in the Treatment of Meibomian Gland Dysfunction	N/A
Recruiting	`NCT05577910` - Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress Therapies for MGD	N/A
Completed	`NCT04889950` - Clinical Study to Evaluate the Safety and Effectiveness of The Tixel Fractional System in the Treatment of Meibomian Gland Disfunction	N/A
Recruiting	`NCT06004895` - Mechanisms of Light-based Therapies for Dry Eye Disease	N/A
Completed	`NCT04147962` - Intense Pulsed Light in Meibomian Gland Dysfunctions
Completed	`NCT02256969` - Intraductal Meibomian Gland Probing Trial	Phase 4
Recruiting	`NCT05089591` - Intense Pulsed Light in Meibomian Gland Dysfunction	N/A
Completed	`NCT04500821` - Evaluation of the LipiFlow System With a New Activator	N/A
Completed	`NCT03318874` - Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction	Phase 4
Completed	`NCT06278584` - iLux Treatment for Meibomian Gland Dysfunction	N/A
Recruiting	`NCT04052841` - Morphological Analysis of Meibomian Glands	N/A
Completed	`NCT05028491` - The Influence of Meibomian Gland Expression on Corneal Aberrations in MGD Patients